Premedication as a Fibrobronchoscopy Safety Factor


Review article surveys premedication as one of the safety methods in flexible endoscopy. The traditional premedication provided technical convenience of bronchoscopy by sedation and secretion drying. This approach had become less justified since bronchoscopy was widely used in patients with severe somatic pathology. This new condition forced the usage of inhalation broncholytics (M-cholinolytics and β2-agonists) which mainly have tracheobronchial impact and minimal systemic action, and parenteral glucocorticosteroids with powerful broncholytic and definite cardioprotective effect. Parenteral administration of theophylline may be used in premedication with some restrictions.

Ключевые слова

Список литературы

1. Zavala D, Godsey K, Bedell GN. The response to atropine sulfate given by aerosol and intramuscular routes to patients undergoing fiberoptic bronchoscopy. Chest.1981;796:512-5.

2. Lukomskii GI, Shulutko ML, Vinner MG, Ovchinnikov AA. Bronkhopul'monologiya. Moskva: Meditsina, 1982. (In Russ.).

3. Davis GS, Brody AR, Landis JM. Quantization of inflammatory activity in interstitial pneumonitis by bronchofiberscopic pulmonary lavage. Chest. 1976;70 (1):265-6.

4. ShubikYuV. Atrial fibrillation: what should be the goal of treatment?Atmosfera. Kardiologiia. 2010;1:2-4.(In Russ.).

5. Hassan G, Qurechi W, Khan GQ, Asmi R. Cardiovascular Consequence of Fiberoptic Bronchoscopy. JK. Science. 2005;7(1):1-2.

6. Nicholson B. Responsible prescribing of oрioids for the management of chronic pain. Drugs. 2003;63(1):17-32.

7. Pan PH, Lee S, Harris L. Chronobiology of subarachnoid fentanyl for labor analgesia. Anesthesiology. 2005;103(3):454-6.

8. GlumcherVS.Anesthetic management of patients with concomitant cardiovascular pathologyOstrye I neotlozhnye sostozniia v praktike vracha.2008;5/6(13). intensivterapia&num=.(In Russ.).

9. Duncan AW, Barr AM. Diazepam premedication and awareness during general anaesthesia for bronchoscopy and laryngoscopy. British. J. of Anesthesia. 1973;45:1150-2.

10. del Cuvillo A, Millol J, Bartra J et al. Comparative pharmacology of H1-antihistamines.J. Invest. Allergol. Clin. Immunol. 2006;16 (1):3-12.

11. Calverley PMA, Scott S. Is airway inflammation in Chronic Obstructive Pulmonary Disease (COPD) a risk factor for cardiovascular events? JChronObstructPulmDis. 2006;3:233-42.

12. Kalashnikov NA.Experience and main directions of fibrobronchoscopy optimization in patients over 80 years of age.Ukrainsrii zhurnal maloinvazivnoi i endoskopichekoi khirurgii. 2000;4(2):6-8.(In Russ.).

13. Strok AB, Galeeva ZhA. Main aspects of use of inhalational medications delivery systems in treatment of upper respiratory tract diseases. Lechebnoe delo.2011;2:10-14.(In Russ.).

14. Barnes PJ. Distribution of receptor targets in the lung. Proc. АmеrThoracSoc. 2004;4(1):345-51.

15. Avdeev SN. Antikholinergicheskie preparaty pri obstruktivnykh zabolevaniyakh legkikh.Aviable at: http: // www.medlinks. ru/article.php?sid=22728.(In Russ.).

16. Stanbrook MB. Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD. Evid. Based Med. 2009;14(2):42-3.

17. McGraw DW., Liggett SB. Molecular mechanisms of beta2-adrenergic receptor function and regulation. Proc. Amer. Thorac. Soc. 2005;2(4):292-6.

18. Wechsler ME, Lehman E, Lazarus SC. Beta-adrenergic receptor polymorphisms and response to salmeterol. AmerJRespirCritCareMed. 2006;173:519-26.

19. Chernekhovskaya NE. Rentgeno-endoskopicheskaya diagnostika zabolevanii organov dykhaniya. MEDpress-inform, 2007. (In Russ.).

20. Stolz D, Pollak V, Chhajed PN et al.A Randomized, Placebo-Controlled Trial of Bronchodilators for Bronchoscopy in Patients With COPD.Chest. 2007;131(3):765-72.

21. Yavelov IS. About safety of long-acting β2-agonists. A cardiologist’s point of view. Pulmonologiia. 2007;1:112-6.(In Russ.).

22. Belousov YuB, Luk'ianov SV, Duhanin AS.Modernconceptsoftheophyllinepharmacodynamics. Kachestvennaia klinicheskaia praktika.2004;3:4-9.(In Russ.).

23. Duffy N, Walker P, Diamantea F. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.Thorax. 2005;60:713-7.

24. NakhosteenJ. Bronchofiberscopy in Asthmatics: a Method for Minimizing Risk of Complications.Respiration. 1978;36:112-6.

25. Mikami K, Suzuki M., Kitagawa H. Efficacy of corticosteroidsin the treatment of community-acquired pneumonia requiring hospitalization. Lung. 2007;185(5):249-55

26. Macie C, Wooldrage K, Manfreda J, Anthonisen NR. Inhaled Corticosteroids and Mortality in COPD.Chest. 2006;130:640-6.

27. Shteiner ML.Premedication for fibrobronchoscopy in chronic obstructive pulmonary disease.Vrach.2014;11:45-7. (InRuss.).

Для цитирования

Shteiner ML. Premedication as a Fibrobronchoscopy Safety FactorScience & Innovations in Medicine. 2018;4(12):59—62.


Send an online application form to the publication